Clinical Trials Sponsored by Pharmaceutical Research Center
Total 15068 results
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsCompletedProstate CancerUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsTerminatedSolid Tumor | Thyroid CancerUnited States
-
Fox Chase Cancer CenterLigand PharmaceuticalsTerminatedParapsoriasisUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsCompletedKidney Cancer | Renal Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterICN PharmaceuticalsCompletedHematological MalignanciesUnited States
-
M.D. Anderson Cancer CenterOSI PharmaceuticalsTerminated
-
Pharmaceutical Research Unit, JordanCompleted
-
Par Pharmaceutical, Inc.Novum Pharmaceutical Research ServicesCompletedTo Determine Bioequivalence Under Fed Conditions
-
Par Pharmaceutical, Inc.Novum Pharmaceutical Research ServicesTerminatedOtitis Media in Patients With Tympanostomy TubesUnited States
-
Par Pharmaceutical, Inc.Novum Pharmaceutical Research ServicesCompletedTo Determine the Bioequivalence Study Under Fasting
-
Fox Chase Cancer CenterJanssen PharmaceuticalsNot yet recruitingUrothelial Carcinoma | Non-Muscle Invasive Bladder Urothelial Carcinoma | Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsRecruitingChronic Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterBellicum PharmaceuticalsRecruiting
-
M.D. Anderson Cancer CenterRegeneron PharmaceuticalsRecruiting
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsTerminated
-
M.D. Anderson Cancer CenterZentalis PharmaceuticalsWithdrawnBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | TumorsUnited States
-
M.D. Anderson Cancer CenterSunesis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsCompletedPolycythemia Vera | Chronic Myelomonocytic Leukemia | Hypereosinophilic Syndrome | Chronic Myeloid Leukemia | MastocytosisUnited States
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsWithdrawnRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsUnknown
-
M.D. Anderson Cancer CenterInex PharmaceuticalsCompletedSoft Tissue Sarcoma | Lymphoma | Leukemia | Osteosarcoma | Wilms' TumorUnited States
-
M.D. Anderson Cancer CenterOrtho PharmaceuticalsTerminatedRectal Cancer | Gastrointestinal CancerUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsTerminatedMyelogenous Leukemia, Chronic, Chronic PhaseUnited States
-
M.D. Anderson Cancer CenterJazz PharmaceuticalsTerminatedLymphoma | Leukemia | Lymphoblastic Lymphoma | Precursor-B Acute Lymphoblastic LeukemiaUnited States
-
Threshold PharmaceuticalsM.D. Anderson Cancer CenterUnknownMelanoma | Pancreatic Cancer | Prostate Cancer | Squamous Cell Carcinoma of the Head and NeckUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsWithdrawnOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
M.D. Anderson Cancer CenterAventis PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterCallisto PharmaceuticalsTerminated
-
Genuine Research Center, EgyptHorus for Pharmaceutical Industries, EgyptCompleted
-
M.D. Anderson Cancer CenterJanssen PharmaceuticaActive, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Aggressive Variant Prostate Carcinoma | Metastatic Prostate Neuroendocrine Carcinoma | Metastatic Prostate Small Cell CarcinomaUnited States
-
PhotocureCatalyst Pharmaceutical ResearchRecruiting
-
Pharmaceutical Research Unit, JordanCompleted
-
Maimonides Medical CenterJohnson & Johnson Pharmaceutical Research & Development, L.L.C.RecruitingAnkle Fractures | Syndesmotic Injuries | Bimalleolar Fractures | Trimalleolar Fractures | Ankle Dislocation | Bimalleolar Equivalent Fracture | Maisonneuve FractureUnited States
-
Cedars-Sinai Medical CenterKos Pharmaceuticals; General Clinical Research Center (GCRC)CompletedCoronary Artery DiseaseUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteRegeneron Pharmaceuticals; Sanofi-SynthelaboRecruitingMerkel Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis Pharmaceuticals; RECORDATI GROUPCompletedNeuroendocrine Tumors | Carcinoid TumorsUnited States
-
Spanish Breast Cancer Research GroupNovartis PharmaceuticalsCompletedBreast Carcinoma Metastatic to the BoneSpain
-
University of Colorado, DenverNational Center for Research Resources (NCRR); Janssen PharmaceuticalsCompletedAnorexia NervosaUnited States
-
Hoosier Cancer Research NetworkPfizer; Novartis PharmaceuticalsCompletedColorectal CancerUnited States
-
Memorial Sloan Kettering Cancer CenterTelix PharmaceuticalActive, not recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Janssen PharmaceuticalsTerminatedProstate CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Aventis PharmaceuticalsCompletedBreast CancerUnited States
-
Centre for Human Drug Research, NetherlandsJanssen PharmaceuticalsRecruiting
-
Algernon PharmaceuticalsCentre for Human Drug Research, NetherlandsActive, not recruiting
-
The Center for Clinical and Cosmetic ResearchAfecta PharmaceuticalsCompletedHand DermatitisUnited States
-
Pennington Biomedical Research CenterTakeda Pharmaceuticals North America, Inc.CompletedDiabetes Mellitus, Type 2United States
-
1st Allergy & Clinical Research CenterCompletedAtopic DermatitisUnited States
-
Metabolic Center of Louisiana Research FoundationAmylin Pharmaceuticals, LLC.CompletedPolycystic Ovary SyndromeUnited States